Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice

被引：0
|
作者：
Tong Li
Jiandong Wang
机构：
[1] Beijing Obstetrics and Gynecology Hospital,Department of Gynecologic Oncology
[2] Capital Medical University,undefined
来源：
BMC Cancer | / 20卷
关键词：
Chimeric antigen receptor T cell; Mucin 16; Programmed cell death-ligand 1; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase I clinical trial of PD-1 knockout anti-MUC1 CAR-T cells in the treatment of patients with non-small cell lung cancer
    Lin, Y.
    Chen, S.
    Zhong, S.
    An, H.
    Yin, H.
    McGowan, E.
    ANNALS OF ONCOLOGY, 2019, 30 : 15 - 15
  • [42] CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth (vol 10, 1149, 2019)
    Zhou, Ru
    Yazdanifar, Mahboubeh
    Roy, Lopamudra Das
    Whilding, Lynsey M.
    Gavrill, Artemis
    Maher, John
    Mukherjee, Pinku
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [43] PRE-CLINICAL EVALUATION OF NOVEL CAR T CELLS TARGETING FOLATE RECEPTOR 1 EXPRESSING HIGH GRADE SEROUS OVARIAN CANCER
    Martinez-Osuna, M.
    Daigre, J.
    Bethke, M.
    Steiner, L.
    Brauner, J.
    Kopatz, J.
    Praveen, P.
    Eckardt, D.
    Bosio, A.
    Herbel, C.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A20 - A20
  • [44] Phase I clinical trial using a unique immunotherapeutic combination of MUC1-targeted CAR-T cells with PD-1-knockout in the treatment of patients with advanced esophageal cancer
    Chen, Size
    Lin, Yiguang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] INTASYL™ PH-762 Self-Delivering RNAi Targeting PD-1 Enhances the Therapeutic Efficacy of Systemically Administered HER2-Targeted CAR-T Cells in a SKOV3 Model of Human Ovarian Adenocarcinoma in NCG Mice
    Cuiffo, Benjamin
    Maxwell, Melissa
    Yan, Dingxue
    Rivest, Brianna
    Cardia, James
    Fricker, Simon P.
    MOLECULAR THERAPY, 2021, 29 (04) : 209 - 209
  • [46] Engineered CAR-T cells targeting the non-functional P2X purinoceptor 7 (P2X7) receptor as a novel treatment for ovarian cancer
    Bandara, Veronika
    Niktaras, Victoria M.
    Willett, Vasiliki J.
    Chapman, Hayley
    Lokman, Noor A.
    Macpherson, Anne M.
    Napoli, Silvana
    Gundsambuu, Batjargal
    Foeng, Jade
    Sadlon, Timothy J.
    Coombs, Justin
    Mccoll, Shaun R.
    Barry, Simon C.
    Oehler, Martin K.
    Ricciardelli, Carmela
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2024, 13 (05)
  • [47] A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells
    Yan, Zhifeng
    Gu, Runxia
    Ma, Haotian
    Chen, Nianci
    Zhang, Ting
    Xu, Yingxi
    Qiu, Shaowei
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    CELLULAR ONCOLOGY, 2024, 47 (05) : 1879 - 1895
  • [48] Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice
    Sun, Ruixin
    Luo, Hong
    Su, Jingwen
    Di, Shengmeng
    Zhou, Min
    Shi, Bizhi
    Sun, Yansha
    Du, Guoxiu
    Zhang, Honghong
    Jiang, Hua
    Li, Zonghai
    MOLECULAR THERAPY, 2021, 29 (01) : 60 - 74
  • [49] A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+recurrent high-grade serous ovarian cancer (HGSOC)
    O'Cearbhaill, R. E.
    Park, J. H.
    Halton, E. F.
    Diamonte, C. R.
    Mead, E.
    Lakhman, Y.
    Kane, P.
    Riviere, I. C.
    Brentjens, R. J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 42 - 42
  • [50] Effect of CRISPR/Cas9-mediated PD-1-disrupted primary human third-generation CAR-T cells targeting EGFRvIII in human glioblastoma cell growth
    Nakazawa, Tsutomu
    Natsume, Atsushi
    Nishimura, Fumihiko
    Matsuda, Ryosuke
    Nakamura, Mitsutoshi
    Nakagawa, Ichiro
    Motoyama, Yasushi
    Park, Young Soo
    Tsujimura, Takahiro
    Wakabayashi, Toshihiko
    Nakase, Hiroyuki
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
12345